Changchun BCHT Biotechnology Co. (SHA:688276)
20.76
-0.35 (-1.66%)
May 22, 2025, 2:45 PM CST
SHA:688276 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 344.87 | 442.18 | 866.54 | 1,156 | 309.63 | Upgrade
|
Cash & Short-Term Investments | 344.87 | 442.18 | 866.54 | 1,156 | 309.63 | Upgrade
|
Cash Growth | -22.01% | -48.97% | -25.01% | 273.22% | 13.42% | Upgrade
|
Accounts Receivable | 1,407 | 1,567 | 968.41 | 763.94 | 733.18 | Upgrade
|
Other Receivables | 2.09 | - | - | - | - | Upgrade
|
Receivables | 1,409 | 1,567 | 968.41 | 763.94 | 733.18 | Upgrade
|
Inventory | 170.78 | 199.02 | 192.11 | 241.34 | 146.19 | Upgrade
|
Prepaid Expenses | - | 0.92 | 0.1 | - | - | Upgrade
|
Other Current Assets | 40.24 | 35.26 | 30.81 | 29.15 | 32.25 | Upgrade
|
Total Current Assets | 1,965 | 2,245 | 2,058 | 2,190 | 1,221 | Upgrade
|
Property, Plant & Equipment | 2,478 | 2,085 | 1,642 | 1,439 | 783.08 | Upgrade
|
Long-Term Investments | 211.34 | 207.57 | 61.28 | 69.12 | 10.23 | Upgrade
|
Other Intangible Assets | 330.6 | 347.45 | 204.02 | 223.72 | 248.57 | Upgrade
|
Long-Term Deferred Tax Assets | 96.28 | 90.97 | 54.2 | 31.93 | 20.96 | Upgrade
|
Long-Term Deferred Charges | 74.68 | 29.26 | 211.09 | 159.25 | 121.57 | Upgrade
|
Other Long-Term Assets | 49.56 | 41.06 | 53.06 | 61.95 | 61.85 | Upgrade
|
Total Assets | 5,205 | 5,046 | 4,284 | 4,175 | 2,468 | Upgrade
|
Accounts Payable | 13.81 | 17.49 | 24.8 | 63.91 | 34 | Upgrade
|
Accrued Expenses | 28.07 | 553.18 | 340.9 | 422.69 | 486.26 | Upgrade
|
Short-Term Debt | 42.9 | 20.47 | - | - | - | Upgrade
|
Current Income Taxes Payable | 6.62 | 48.89 | 5.07 | - | 18.24 | Upgrade
|
Current Unearned Revenue | 2.2 | 0.28 | 8.65 | 10.21 | 6.25 | Upgrade
|
Other Current Liabilities | 823.46 | 374.56 | 337.27 | 251.89 | 134.94 | Upgrade
|
Total Current Liabilities | 917.07 | 1,015 | 716.68 | 748.71 | 679.69 | Upgrade
|
Long-Term Debt | 59.93 | - | - | - | - | Upgrade
|
Long-Term Unearned Revenue | 9 | 9.86 | 5.92 | 8.09 | 7.88 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.88 | 0.98 | 1.11 | - | - | Upgrade
|
Other Long-Term Liabilities | 0.24 | 0.17 | 0.31 | 0.25 | - | Upgrade
|
Total Liabilities | 987.12 | 1,026 | 724.02 | 757.05 | 687.57 | Upgrade
|
Common Stock | 413.66 | 412.84 | 412.84 | 412.84 | 371.56 | Upgrade
|
Additional Paid-In Capital | 1,840 | 1,820 | 1,778 | 1,771 | 416.29 | Upgrade
|
Retained Earnings | 1,989 | 1,819 | 1,380 | 1,240 | 1,023 | Upgrade
|
Comprehensive Income & Other | -25.27 | -31.86 | -10.96 | -5.75 | -30.89 | Upgrade
|
Shareholders' Equity | 4,218 | 4,020 | 3,560 | 3,418 | 1,780 | Upgrade
|
Total Liabilities & Equity | 5,205 | 5,046 | 4,284 | 4,175 | 2,468 | Upgrade
|
Total Debt | 102.83 | 20.47 | - | - | - | Upgrade
|
Net Cash (Debt) | 242.04 | 421.71 | 866.54 | 1,156 | 309.63 | Upgrade
|
Net Cash Growth | -42.60% | -51.33% | -25.01% | 273.22% | 186.74% | Upgrade
|
Net Cash Per Share | 0.58 | 1.02 | 2.10 | 2.94 | 0.84 | Upgrade
|
Filing Date Shares Outstanding | 415.25 | 412.84 | 412.84 | 412.84 | 371.56 | Upgrade
|
Total Common Shares Outstanding | 415.25 | 412.84 | 412.84 | 412.84 | 371.56 | Upgrade
|
Working Capital | 1,048 | 1,230 | 1,341 | 1,441 | 541.56 | Upgrade
|
Book Value Per Share | 10.16 | 9.74 | 8.62 | 8.28 | 4.79 | Upgrade
|
Tangible Book Value | 3,887 | 3,673 | 3,356 | 3,194 | 1,531 | Upgrade
|
Tangible Book Value Per Share | 9.36 | 8.90 | 8.13 | 7.74 | 4.12 | Upgrade
|
Buildings | - | 487.92 | 374.62 | 307.51 | 324.89 | Upgrade
|
Machinery | - | 826.34 | 509.79 | 451.85 | 426.37 | Upgrade
|
Construction In Progress | - | 1,101 | 1,038 | 919.84 | 235.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.